Delivery Order SPE2DB25D9760-SPE2DB25FXRWK

Award Date 3/28/25
Potential Completion Date 4/18/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,471.55 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product, with a period of performance through March 13, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of prescription drugs, over-the-counter...
The Defense Logistics Agency (DLA) awarded a $3,573.45 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a $10,720.35 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, with a period of performance through May 21, 2024. This delivery order was placed under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows for the supply of a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $4,288.14 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,384,225 units of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at $499,999,999 and valid...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,717.52 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,419,389 units of the NEXPLANON 68 MG IMPLANTS pharmaceutical product. This delivery order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA, valued at $499,999,999 and valid through November 2026. The IDC allows DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $34,305.12, is for the procurement of 68 mg NEXPLANON implants. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,288.14, is for the supply of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $34,305.12 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, a specialized pharmaceutical product, with a period of performance through May 17, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,404.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,720.35 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,322,088 NEXPLANON 68 MG contraceptive implants. This delivery order is part of a larger indefinite delivery contract valued at up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products to military health...
  • SPE2DB25D9760
    Indefinite Delivery Contract
  • SPE2DB25D9760-SPE2DB25FXRWK
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,165.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 6/27/25, 12:00 PM